Clin2
NCT07704255Possibly a fitRecruiting

Fecal transplant for stubborn H. pylori infection

Helicobacter Pylori Infection

Part of Digestive system, Infections clinical trials.

This study tries a fecal microbiota transplant (placing healthy donor stool into your gut) to get rid of stubborn H. pylori infection that hasn't been cured by standard treatments. It's for people who have failed several rounds of therapy and have a stomach condition that makes eradication important.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
10 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 to 70 years old.
  • Standard H. pylori treatments have failed you at least 4 times.
  • You have a stomach condition such as early stomach cancer, an ulcer, a type of lymphoma called MALT, or atrophic gastritis.
  • You haven't taken antibiotics or bismuth in the last 4 weeks, or acid-reducing medicines like omeprazole in the last 2 weeks.
  • You are not pregnant or breastfeeding.
  • You have no other serious diseases or problems that would make the study unsafe for you.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07405697Not yet recruiting· Phase 4
Personalized treatment for stubborn H. pylori infection

This study tests a new way to choose antibiotics for H. pylori infection when the usual treatment has failed. By looking at your stool sample, doctors can pick the medicine most likely to work for you.

Shanghai, Shanghai Municipality
NCT07272681Not yet recruiting
Treating H. pylori to improve stomach and gut symptoms

This trial tests whether getting rid of an H. pylori infection in your stomach can help reduce symptoms like pain, bloating, or nausea. If you have this infection and stomach or gut issues, this treatment might make you feel better.

NCT07827170Not yet recruiting
Probiotics with standard H. pylori treatment

This study tests whether adding a probiotic (a healthy bacteria supplement) to the standard four-drug treatment for H. pylori infection helps get rid of the bacteria better and with fewer side effects. It may help make your treatment more effective and easier to tolerate.

Hanoi
NCT06200779Not yet recruiting· Phase 4
Personalized versus standard treatment for H. pylori infection

This study is testing whether giving H. pylori treatment based on the specific bacteria found in your stomach works better than the standard one-size-fits-all approach. If you are already getting an endoscopy with a biopsy, this trial could help find the most effective medication for your infection.

Porto, Porto District
NCT07139366Recruiting· Phase 4
Probiotic plus bismuth combo for stubborn H. pylori

This study tests a combination of a probiotic (Saccharomyces boulardii) plus a standard bismuth-based four-drug treatment for people whose H. pylori infection has not been cured by previous treatments. It aims to see if adding the probiotic helps the treatment work better and cause fewer side effects.

Xi'an, Shaanxi
NCT05121025Recruiting
Study of stomach bacteria and gut microbes in Helicobacter infection

This study looks at how stomach bacteria (Helicobacter pylori) interact with the normal microbes in your gut. You may be asked to provide tissue, stool, and blood samples to help researchers understand infection and the body’s response.

Freiburg im Breisgau, Baden-Wurttemberg

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.